William D. Turner
Chief Regulatory Officer · Vera Therapeutics, Inc.
- 2025
- Feb 26, 2026
- 5
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies William D. Turner files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Marshall Fordyce - $7.10M in VERA purchases and sales in the last 12 months
- Joseph R. Young - $567K in VERA purchases and sales in the last 12 months
- Sean Grant - $208K in VERA purchases and sales in the last 12 months
- David Lee Johnson - $108K in VERA purchases and sales in the last 12 months
- Jason S. Carter - $107K in VERA purchases and sales in the last 12 months
- Robert Brenner - $90K in VERA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is William D. Turner?
William D. Turner is a corporate insider, tracked as Chief Regulatory Officer of Vera Therapeutics, Inc. (VERA). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did William D. Turner last file a Form 4?
The most recent primary Form 4 on record is dated 26 February 2026, one of 5 filings going back to 2025.
Has William D. Turner been buying or selling stock?
Recorded transactions: 0 open-market purchases and 4 open-market sales ($1.45M) across all tracked filings.
